We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

104 hedge funds and large institutions have $135M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 34

9% less funds holding

Funds holding: 114104 (-10)

35% less capital invested

Capital invested by funds: $209M → $135M (-$73.1M)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

95% less call options, than puts

Call options by funds: $24K | Put options by funds: $506K

Holders
104
Holders Change
-10
Holders Change %
-8.77%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
14
Increased
42
Reduced
34
Closed
24
Calls
$24K
Puts
$506K
Net Calls
-$482K
Net Calls Change
+$106K
Name Holding Trade Value Shares
Change
Change in
Stake
BC
1
Broadfin Capital
New York
$19.2M +$4.86M +101,490 +20%
ACA
2
Avoro Capital Advisors
New York
$19M +$22.7M +475,439 +380%
AC
3
Armistice Capital
New York
$15.2M +$23M +480,000 New
BFA
4
BlackRock Fund Advisors
California
$6.37M +$1.59M +33,194 +20%
AC
5
Aisling Capital
New York
$6.35M
ECP
6
Elk Creek Partners
Colorado
$5.89M +$1.09M +22,808 +14%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.5M +$3.96M +82,812 +91%
TC
8
TFS Capital
Pennsylvania
$4.15M +$6.17M +128,980 +5,543%
BIT
9
BlackRock Institutional Trust
California
$3.57M +$141K +2,942 +3%
ACP
10
Acuta Capital Partners
California
$3.5M +$5.3M +110,872 New
O
11
OrbiMed
New York
$3.39M
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$3.32M +$2.51M +52,501 +100%
JAM
13
Jupiter Asset Management
United Kingdom
$2.87M +$356K +7,445 +9%
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$2.56M -$52.7K -1,101 -1%
Charles Schwab
15
Charles Schwab
California
$2.53M +$445K +9,310 +13%
WSA
16
Wall Street Associates
California
$2.2M -$2.48M -51,910 -43%
DCM
17
DG Capital Management
New York
$2.2M +$45.6K +954 +1%
KCM
18
Kennedy Capital Management
Missouri
$1.92M -$896K -18,727 -24%
RCMC
19
RK Capital Management (Colorado)
Colorado
$1.9M -$2.7M -56,448 -48%
State Street
20
State Street
Massachusetts
$1.7M +$378K +7,893 +17%
Renaissance Technologies
21
Renaissance Technologies
New York
$1.47M +$1.95M +40,658 +713%
Northern Trust
22
Northern Trust
Illinois
$1.45M +$505K +10,561 +30%
AQR Capital Management
23
AQR Capital Management
Connecticut
$1.37M +$1.03M +21,468 +99%
Ameriprise
24
Ameriprise
Minnesota
$1.28M +$342K +7,145 +21%
KIA
25
Kopp Investment Advisors
Minnesota
$1.19M -$60.8K -1,271 -3%

PTX Hedge Fund Activity: Q3 2015 in Review

104 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2015, worth a combined $135M — down 35% from $209M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PTX and 14 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 42 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $23M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $14.8M sold.

  • 104 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2015, down from 114 in Q2 2015.
  • Funds reported $135M of Pernix Therapeutics Holdings, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
  • 14 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2015 and 24 closed out, a net change of -10 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2015 was Armistice Capital, an estimated $23M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2015 was Janus Henderson Investors US, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2015.